MENU
LFSC
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

LFSC stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
LFSC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for LFSC with price predictions
Jun 12, 2026

LFSC's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for LFSC turned positive on June 11, 2026. Looking at past instances where LFSC's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 11, 2026. You may want to consider a long position or call options on LFSC as a result. In of 24 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFSC advanced for three days, in of 91 cases, the price rose further within the following month. The odds of a continued upward trend are .

LFSC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 80 cases where LFSC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFSC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Guardant Health (NASDAQ:GH), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Market Cap

The average market capitalization across the F/m Emerald Life Sciences Innovation ETF ETF is 5.7B. The market cap for tickers in the group ranges from 376.33M to 23.17B. UTHR holds the highest valuation in this group at 23.17B. The lowest valued company is OFIX at 376.33M.

High and low price notable news

The average weekly price growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was 6%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 3%. WGS experienced the highest price growth at 15%, while OFIX experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was -20%. For the same stocks of the ETF, the average monthly volume growth was -30% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 71
P/E Growth Rating: 77
Price Growth Rating: 54
SMR Rating: 83
Profit Risk Rating: 81
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
LFSC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
LFSC's MACD Histogram crosses above signal line